Austria as an Innovation Hub: Experts Discuss the Future of Life Sciences
Austria is increasingly positioning itself as a key location for medical research and technological development. As part of the current "Schiefer Talks," leading industry experts gathered to discuss the country's potential as a "health innovation hub." The central focus was on how Austria can further expand its strengths in the life sciences sector.
Participants in the discussion included Andreas Köttl, President of VÖPE and ÖGNI, as well as Barbara Sladek, founder and CEO of the company myBioma. Together with other experts such as Pavol Dobrocky, they analyzed the current challenges and opportunities for companies in the healthcare sector. A key topic was the connection between scientific research and economic implementation.
The experts emphasized that Austria possesses an excellent infrastructure and highly qualified professionals. These factors are crucial for successfully bringing innovative health products to the international market. In particular, digitalization in healthcare and personalized medicine were identified as areas where Austrian companies are already playing a pioneering role today.
In conclusion, the participants agreed that close cooperation between policymakers, research institutions, and the private sector is necessary. Only through joint investments and clear framework conditions can Austria sustainably consolidate its position as a leading location for health innovations in Europe. The exchange underscored the importance of the sector for the country's future economic development.